Bryan Scott Ganz and related reporting persons are deemed to control voting and dispositive power over 2,296,635 Byrna common shares, equal to 9.6%, while Matt McBrady joins the proposed board slate. Investors now have a board-contest development to track, with Ganz also seeking reconsideration of a second candidate.

Key Highlights

  • Matt McBrady served on Axon’s board from 2001 to 2014 and again from 2016 through 2026.
  • Ganz’s reported position includes 984,323 directly held shares and Options for up to 516,667 additional shares.
  • Ganz reported holding 984,323 Byrna common shares and options for up to 516,667 additional shares exercisable within 60 days.
  • Matt McBrady will join Byrna’s proposed board slate, bringing less-lethal-market experience from service on Axon’s board.

Ganz Position Includes Shares, Options and Affiliated Holdings

The group disclosed that Matt McBrady will join Byrna (NASDAQ: BYRN)’s proposed board slate. The reported position includes 984,323 Byrna common shares held by Ganz, plus options for up to 516,667 shares exercisable within 60 days. The options were described as out-of-the-money. Byrna’s common stock has a $0.001 Par Value per share.

McBrady Joins Proposed Board Slate

Ganz said McBrady brings experience in the less-lethal market from his service on Axon’s board from 2001 to 2014 and again from 2016 through 2026. Ganz said the Byrna board’s decision to include McBrady followed conversations in which he presented two board candidates. He expressed disappointment that the second candidate was not included and said he hoped the board would reconsider that person as part of its stated goal of upgrading the board.